MARKET

SCLX

SCLX

Scilex Holding Co
NASDAQ
12.53
+0.33
+2.70%
Opening 12:18 01/02 EST
OPEN
12.18
PREV CLOSE
12.20
HIGH
12.75
LOW
12.18
VOLUME
10.98K
TURNOVER
--
52 WEEK HIGH
34.27
52 WEEK LOW
3.600
MARKET CAP
106.40M
P/E (TTM)
-0.3776
1D
5D
1M
3M
1Y
5Y
1D
Scilex appoints Kasowitz LLP as litigation, IP counsel
TipRanks · 3h ago
Scilex Holding Company Appoints Kasowitz LLP for Litigation and IP Counsel
Reuters · 3h ago
Scilex Holding Company Appoints Kasowitz LLP as Litigation and Intellectual Property Counsel
Barchart · 9h ago
Scilex Holding Company Reports Disposal of Common Shares
Reuters · 12/31/2025 01:24
Scilex Completes Warrant Repurchase, Strengthening Capital Structure
TipRanks · 12/30/2025 20:57
Scilex Completes $27 Million Repurchase of Oramed Penny Warrants
Reuters · 12/30/2025 20:38
Weekly Report: what happened at SCLX last week (1222-1226)?
Weekly Report · 12/29/2025 09:46
Scilex confirms Dream Bowl 2026 Meme Coin claim process
TipRanks · 12/23/2025 14:05
More
About SCLX
Scilex Holding Company is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company’s commercial products include ZTlidoO (lidocaine topical system) 1.8% for the relief of neuropathic pain associated with postherpetic neuralgia (PHN); ELYXYB, a ready-to-use oral solution for the acute treatment of migraine, with or without aura, in adults; and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults. In addition, it focuses on product candidates, including SP-102 (10 mg, dexamethasone sodium phosphate viscous gel) (SEMDEXAO), an epidural injections formulation to treat lumbosacral radicular pain, or sciatica; SP-103 (lidocaine topical system) 5.4%, a ZTlido formulation, for the treatment of acute pain; and SP-104 (4.5 mg, low-dose naltrexone hydrochloride delayed-release capsules) (SP-104) for fibromyalgia treatment.

Webull offers Scilex Holding Co stock information, including NASDAQ: SCLX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SCLX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SCLX stock methods without spending real money on the virtual paper trading platform.